Scarica l'app Stockscreener
33.24
4.33%
1.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Earnings Recap: Will Castle Biosciences Inc stock go up in YEAR2025 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN
EV Market: Can Castle Biosciences Inc deliver alpha2025 Stock Rankings & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Aug Weekly: Can Castle Biosciences Inc. maintain its current growth rateEarnings Overview Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Castle Biosciences (CSTL) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Castle Biosciences, Inc. $CSTL Shares Sold by Allianz Asset Management GmbH - MarketBeat
Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 49.91% Upside Potential for Investors - DirectorsTalk Interviews
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 3,200 Shares of Stock - MarketBeat
Derek Maetzold Sells 817 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
What Catalysts Are Rewriting The Castle Biosciences (CSTL) Story For Wall Street Analysts - Yahoo Finance
Neurocrine Biosciences to Report Q4 Earnings: What's in the Cards? - Finviz
Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026 - The Manila Times
Castle Biosciences to Release Fourth Quarter and Full-Year - GlobeNewswire
Castle Biosciences Enters Oversold Territory (CSTL) - Nasdaq
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Retail Trends: Should you avoid Castle Biosciences Inc stock right nowQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
The Analyst Verdict: Castle Biosciences In The Eyes Of 7 Experts - Benzinga
Are you looking for a top momentum pick? Why Castle Biosciences, Inc. (CSTL) is a great choice - MSN
Aug Outlook: How sensitive is Castle Biosciences Inc to inflationMarket Risk Report & Entry Point Strategy Guides - baoquankhu1.vn
AIGH Capital Management LLC Acquires New Position in Castle Biosciences, Inc. $CSTL - Defense World
Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and 9.13% Upside Potential - DirectorsTalk Interviews
Castle Biosciences stock hits 52-week high at $42.25 By Investing.com - Investing.com Nigeria
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 4,017 Shares - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month HighWhat's Next? - MarketBeat
Castle Biosciences stock hits 52-week high at $42.25 - Investing.com
26,996 Shares in Castle Biosciences, Inc. $CSTL Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Risk Hedge: What are the future prospects of Castle Biosciences IncCPI Data & Daily Volume Surge Signals - baoquankhu1.vn
Insider Buy: What are the future prospects of Castle Biosciences IncQuarterly Market Review & Free Community Supported Trade Ideas - baoquankhu1.vn
Zacks.com Spotlights Perimeter Solutions, Interface, Castle Biosciences, and Great Lakes Dredge & Dock - Intellectia AI
Market Rankings: How sensitive is Castle Biosciences Inc to inflationJuly 2025 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
Dividend Watch: How sensitive is Castle Biosciences Inc. to inflationAnalyst Downgrade & Weekly Return Optimization Plans - baoquankhu1.vn
Market Trends: Will Castle Biosciences Inc stock deliver better than expected guidance - Bộ Nội Vụ
Castle Biosciences (CSTL) Gets a Buy from Lake Street - The Globe and Mail
Castle Biosciences (CSTL) Sees PT Raised by Lake Street: Analyst Insights | CSTL Stock News - GuruFocus
Castle Biosciences (CSTL) Valuation After Upgraded 2025 Guidance And Strong Core Test Volume Growth - Yahoo Finance
The Bull Case For Castle Biosciences (CSTL) Could Change Following Surging Test Volumes And Raised 2025 Outlook - Yahoo Finance
Castle Biosciences (CSTL) Expects 2025 Revenue to Surpass $340 M - GuruFocus
Castle Biosciences Expects 2025 Revenue to Exceed $340 Million - Intellectia AI
Castle Biosciences 2025 total revenue expected to exceed $340 million - marketscreener.com
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results - The Manila Times
Castle Biosciences 2025 Total Revenue Expected To Exceed $340 Million - TradingView — Track All Markets
San Gabriel Valley Tribune - FinancialContent
Castle Biosciences to buy Previse - MSN
Castle Biosciences, Inc. (CSTL) Stock Analysis: Riding the Wave of Healthcare Innovation with 9.68% Upside Potential - DirectorsTalk Interviews
Can Castle Biosciences Inc. stock continue upward trendWeekly Profit Analysis & Daily Profit Maximizing Tips - Улправда
What risks investors should watch in Castle Biosciences Inc. stock2025 Support & Resistance & AI Powered Buy/Sell Recommendations - Улправда
How resilient is Castle Biosciences Inc. stock in market downturnsShare Buyback & Consistent Return Investment Signals - ulpravda.ru
Why Castle Biosciences Inc. stock is considered a top pickBull Run & Weekly High Potential Alerts - ulpravda.ru
Is Castle Biosciences Inc. stock near bottom after declineRisk Management & Reliable Breakout Forecasts - Улправда
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 1,339 Shares of Stock - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 2,678 Shares of Stock - MarketBeat
0.24%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):